Age-Related Scattered Hypofluorescent Spots as an Adverse Prognostic Factor for Polypoidal Choroidal Vasculopathy. [PDF]
Kim SH +7 more
europepmc +1 more source
Polypoidal Choroidal Vasculopathy: From Clinicopathological and Molecular Perspectives.
Zhang C +4 more
europepmc +1 more source
Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study. [PDF]
Wang TI +6 more
europepmc +1 more source
Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases - The FAR-PEARL Study Report 1. [PDF]
Fong KCS +5 more
europepmc +1 more source
Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial. [PDF]
Chong YJ +14 more
europepmc +1 more source
Fundus Autofluorescence (FAF) Alteration in Polypoidal Choroidal Vasculopathy (PCV) and Typical Neovascular Age Related Macular Degeneration (tAMD). [PDF]
Ong C +7 more
europepmc +1 more source
Early anatomical outcomes of faricimab vs aflibercept 2 mg in treatment-naïve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: A head-to-head comparative study in Taiwan. [PDF]
Yang CC +6 more
europepmc +1 more source
Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy [PDF]
Akaza +25 more
core +2 more sources
Six Cases of Polypoidal Choroidal Vasculopathy in Eyes with Choroidal Nevi. [PDF]
Gaggino A +4 more
europepmc +1 more source

